4:34 PM
Jul 08, 2013
 |  BC Extra  |  Financial News

Conatus sets IPO range

Conatus Pharmaceuticals Inc. (San Diego, Calif.) amended its IPO and new plans to sell 5 million shares at $10-$12. At the $11 midpoint, Conatus would raise $55 million and be valued at $160.3...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >